Pharmacy closures across the U.S. are driving significant declines in medication adherence among Americans, a recent study has found, especially those who are older and live in neighborhoods with low accessibility.

A cardiologist at St. Joseph’s Hospital in Syracuse, N.Y., is one of 60 that’s been charged in an illegal prescription opioid scandal that spans the U.S.

Several professional medical societies have now weighed in on a bill introduced to Congress on April 9 which seeks to prevent physicians from self-referring Medicare patients to in-office “ancillary services” including advanced imaging, anatomic pathology, radiation therapy and physical therapy.

The FDA’s decision to mandate labeling of added sugar content on packaged foods and beverages is estimated to prevent nearly 1 million cases of diabetes and cardiovascular disease over the next 20 years and save the U.S. $31 billion in net healthcare costs over that timeframe.

An April 2 story in the New York Times highlighted a potentially dangerous insurance coverage gap faced by heart transplant patients and recipients of other organs—the immunosuppressive drugs they need to prevent organ rejection sometimes aren’t covered by Medicare if they received the transplants before enrolling in the program.

French drugmaker Sanofi announced on April 10 a plan to lower its insulin prices to $99 per month for some U.S. patients, beginning in June. The announcement came amid a series of congressional hearings about drug costs and was met with questions about why this move and other recent cost-cutting measures took so long.

Dietary risk factors—such as consuming too much sodium or not enough whole grains and fruits—were responsible for 11 million deaths globally in 2017, according to a new analysis in The Lancet.

The actual cost of a heart attack or stroke to society is about double the direct medical costs when lost productivity for patients and caregivers is considered, according to a study published April 6 in the European Journal of Preventive Cardiology.